Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines. [PDF]
Rev Saude PublicaBrito Junior I +5 more
europepmc +1 more source
[Asymmetries between national articulation and the autonomy of state governments in implementing health technologies to fight COVID-19 in Argentina]. [PDF]
Cad Saude PublicaHasdeu S +3 more
europepmc +1 more source
Familiar Dermatologic Drugs as Therapies for COVID-19. [PDF]
Actas Dermosifiliogr, 2021 Ortega-Peña M, González-Cuevas R.
europepmc +1 more source
Using the new guideline for diagnosing anthelmintic resistance of gastrointestinal nematodes to different chemical components in sheep in the Rio Grande do Norte State, Brazil. [PDF]
Rev Bras Parasitol VetLima Júnior V +10 more
europepmc +1 more source
Intervenção com ivermectina para COVID-19 (SARS-Cov 2): sinopse baseada em evidências
, 2021 Person OC +3 more
europepmc +1 more source
COVID-19: The Ivermectin African Enigma. [PDF]
Colomb Med (Cali), 2020 Guerrero R +4 more
europepmc +1 more source
Reduction of egg reappearance period of cyathostomins in naturally infected horses after increasing doses of ivermectin in Brazil: a grim picture for sustainable parasite control. [PDF]
Rev Bras Parasitol VetMolento MB +4 more
europepmc +1 more source
[Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment]. [PDF]
Enferm Infecc Microbiol Clin, 2023 Rodríguez-Guardado A +7 more
europepmc +1 more source
[Comments to the document GEPI-SEIMC screening recommendations for patients with suspected strongyloidosis]. [PDF]
Enferm Infecc Microbiol Clin, 2022 Wikman-Jorgensen P +3 more
europepmc +1 more source
[Cauda equina syndrome in HIV patient]. [PDF]
Rev Esp Quimioter, 2021 Muñoz-Muñoz L +3 more
europepmc +1 more source